BioMarin’s Voxzogo obtains Japan’s MHLW approval for achondroplasia
In a Phase III trial, treatment with Voxzogo offered transient declines in blood pressure.
Global Healthcare and Pharma Market Outlook
Latest in
Global Healthcare and Pharma Market Outlook
Longevity technology and its future
Despite developments, epigenetic clocks and similar longevity technologies remain expensive.
By
Takeda to transfer marketing authorisation for Spikevax in Japan to Moderna
The vaccine obtained authorisation from the Ministry of Health, Labour and Welfare of Japan to prevent Covid-19.
How prepared are US stockpiles for the monkeypox outbreak?
In addition to an approved drug and vaccine, US agencies are negotiating the procurement of a second antiviral to bolster…
By
AnGes and Eiger collaborate to distribute Zokinvy in Japan
AnGes will make upfront and milestone payments up to $1.5m to Eiger, under the deal.
Moderna seeks expanded CMA in EU for Covid-19 vaccine in children
The authorisation is based on the positive interim findings from the Phase II/III KidCOVE clinical trial of the vaccine.
Factors to consider for wider market penetration of Outlook Therapeutics’ ONS-5010
On March 31, 2022, Outlook Therapeutics submitted a Biologics License Application (BLA) to the FDA for ONS-5010 (bevacizumab-vikg) for the…
By
Japan’s MHLW grants approval for Takeda’s Covid-19 vaccine
Takeda will manufacture the vaccines at its Hikari facility in Japan for supply in the country.